Paper22129166
Effect of pregnancy on emtricitabine pharmacokinetics.
Stek AM and 12 others. HIV Med, 2012. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Effect of pregnancy on emtricitabine pharmacokinetics. Papers, record 22129166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22129166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Deoxycytidine | Major topic |
| HIV Infections | Major topic |
| Pregnancy Complications, Infectious | Major topic |
| Adult | |
| Area Under Curve | |
| Emtricitabine | |
| Female | |
| Humans | |
| Inhibitory Concentration 50 | |
| Metabolic Clearance Rate | |
| Postpartum Period | |
| Pregnancy | |
| Pregnancy Trimester, Third | |
| Prospective Studies | |
| Viral Load | |
| Young Adult |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HHSN267200800001G | NIDDK NIH HHS | United States | PubMed | PubMed | |
| U01 AI068632 | NIAID NIH HHS | United States | U01AI068632 | PubMed and NIH | NIH RePORTER |
| UM1 AI068632 | NIAID NIH HHS | United States | U01AI068632 | PubMed and NIH | NIH RePORTER |
| U01 AI068616 | NIAID NIH HHS | United States | U01AI068616 | PubMed and NIH | NIH RePORTER |
| HHSN267200800001C | NICHD NIH HHS | United States | PubMed | PubMed | |
| U01 AI041110 | NIAID NIH HHS | United States | U01AI041110 | PubMed and NIH | NIH RePORTER |
| M01 RR000043 | NCRR NIH HHS | United States | M01RR000043 | PubMed and NIH | NIH RePORTER |
| AI068632 | NIAID NIH HHS | United States | U01AI068632 | PubMed and NIH | NIH RePORTER |
| 1 U01 AI068616 | NIAID NIH HHS | United States | U01AI068616 | PubMed and NIH | NIH RePORTER |
| 5 U01 AI41110 | NIAID NIH HHS | United States | U01AI041110 | PubMed and NIH | NIH RePORTER |
| UM1AI068632 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00042289 | Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy | Results |
Source ClinicalTrials.gov
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9780252 | Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9780252 | PubMed |
| 2 | 17414929 | Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137. | J Acquir Immune Defic Syndr | 2007 | https://conductscience.org/library/papers/17414929 | PubMed |
| 3 | 15588339 | Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection. | AIDS Res Hum Retroviruses | 2004 | https://conductscience.org/library/papers/15588339 | PubMed |
| 4 | 19104016 | Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19104016 | PubMed |
| 5 | 16470119 | Impact of pregnancy on abacavir pharmacokinetics. | AIDS | 2006 | https://conductscience.org/library/papers/16470119 | PubMed |
| 6 | 21283017 | Atazanavir pharmacokinetics with and without tenofovir during pregnancy. | J Acquir Immune Defic Syndr | 2011 | https://conductscience.org/library/papers/21283017 | PubMed |
| 7 | 17519400 | Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. | J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17519400 | PubMed |
| 8 | 21078458 | Antiretroviral pharmacology: special issues regarding pregnant women and neonates. | Clin Perinatol | 2010 | https://conductscience.org/library/papers/21078458 | PubMed |
| 9 | 15551216 | Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. | J Infect Dis | 2004 | https://conductscience.org/library/papers/15551216 | PubMed |
| 10 | 8098905 | The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. | Am J Obstet Gynecol | 1993 | https://conductscience.org/library/papers/8098905 | PubMed |
| 11 | 20632458 | Lopinavir tablet pharmacokinetics with an increased dose during pregnancy. | J Acquir Immune Defic Syndr | 2010 | https://conductscience.org/library/papers/20632458 | PubMed |
| 12 | 7758253 | Placental transfer of drugs administered to the mother. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7758253 | PubMed |
| 13 | 15504861 | Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15504861 | PubMed |
| 14 | 16988514 | Reduced lopinavir exposure during pregnancy. | AIDS | 2006 | https://conductscience.org/library/papers/16988514 | PubMed |
| 15 | 20622674 | Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women. | J Acquir Immune Defic Syndr | 2010 | https://conductscience.org/library/papers/20622674 | PubMed |
| 16 | 14982771 | Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14982771 | PubMed |
| 17 | 17526857 | Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers. | J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17526857 | PubMed |
| 18 | 18366444 | Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. | HIV Med | 2008 | https://conductscience.org/library/papers/18366444 | PubMed |
| 19 | 15905735 | Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. | J Acquir Immune Defic Syndr | 2005 | https://conductscience.org/library/papers/15905735 | PubMed |
| 20 | 9391746 | Pharmacokinetic changes during pregnancy and their clinical relevance. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9391746 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42090286 | Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42090286 | PubMed |
| 41901296 | From Pharmacovigilance Signals to Mechanistic Phenotypes: Integrating ADMET, PK/PD, and Network Context to Interpret Antiviral Safety in Pregnancy. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901296 | PubMed |
| 39487018 | Care of Pregnant Women Living with Human Immunodeficiency Virus. | Clin Perinatol | 2024 | https://conductscience.org/library/papers/39487018 | PubMed |
| 35067869 | Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35067869 | PubMed |
| 33527213 | Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/33527213 | PubMed |
| 32592111 | Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models. | J Pharmacokinet Pharmacodyn | 2020 | https://conductscience.org/library/papers/32592111 | PubMed |
| 31529598 | Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards? | J Int AIDS Soc | 2019 | https://conductscience.org/library/papers/31529598 | PubMed |
| 31489678 | Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir. | J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31489678 | PubMed |
| 31160284 | Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31160284 | PubMed |
| 29369162 | Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. | AIDS | 2018 | https://conductscience.org/library/papers/29369162 | PubMed |
| 28426519 | Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding. | Curr Opin HIV AIDS | 2017 | https://conductscience.org/library/papers/28426519 | PubMed |
| 27802281 | Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. | PLoS Med | 2016 | https://conductscience.org/library/papers/27802281 | PubMed |
| 27490637 | Advancing HIV research with pregnant women: navigating challenges and opportunities. | AIDS | 2016 | https://conductscience.org/library/papers/27490637 | PubMed |
| 26518984 | Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26518984 | PubMed |
| 26011128 | Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/26011128 | PubMed |
| 25407158 | Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. | HIV Med | 2015 | https://conductscience.org/library/papers/25407158 | PubMed |
| 25281357 | Basic obstetric pharmacology. | Semin Perinatol | 2014 | https://conductscience.org/library/papers/25281357 | PubMed |
| 25223699 | Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/25223699 | PubMed |
| 24995851 | Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24995851 | PubMed |
| 24575394 | Obstetric Pharmacokinetic Dosing Studies are Urgently Needed. | Front Pediatr | 2014 | https://conductscience.org/library/papers/24575394 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Drugs40
The drugs whose trials, in the Pipelines release, list the paper.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22129166
GET https://conductscience.org/api/papers/v1/22129166/references?page=2